Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

Findings indicate that frequent COVID-19 booster shots do not weaken T-cell responses, alleviating concerns for vulnerable groups facing new variants.

In a human-mouse xenogeneic GvHD (xGvHD) model, ALTB-268 significantly improved survival, reduced disease severity score and body weight loss, and decreased human CD4+ and CD8+ T cells, while ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A new platform comprehensively profiles CAR T-cells during manufacturing, revealing phenotypic shifts. This allows for ...

The following highlights showcase late-breaking research presented at the European Association for the Study of the Liver ...

KAIST-KRIBB Develops 'FiNi-seq' Technology to Capture Characteristics of Fibrotic Microenvironments Accumulated in Liver ...

AstriVax begins clinical development of AVX70371, a hepatitis B immunotherapy using Launch-iT technology: Leuven, Belgium Saturday, June 7, 2025, 10:00 Hrs [IST] AstriVax Therapeu ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for ...